Lipid metabolism and tumor immunotherapy

In recent years, the relationship between lipid metabolism and tumour immunotherapy has been thoroughly investigated. An increasing number of studies have shown that abnormal gene expression and ectopic levels of metabolites related to fatty acid synthesis or fatty acid oxidation affect tumour metas...

Full description

Bibliographic Details
Main Authors: Yue Wang, Zongjin Guo, Adamu Danbala Isah, Shuangwei Chen, Yongfei Ren, Huazhong Cai
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2023.1187989/full
_version_ 1797344439896637440
author Yue Wang
Yue Wang
Yue Wang
Zongjin Guo
Adamu Danbala Isah
Shuangwei Chen
Yongfei Ren
Huazhong Cai
Huazhong Cai
author_facet Yue Wang
Yue Wang
Yue Wang
Zongjin Guo
Adamu Danbala Isah
Shuangwei Chen
Yongfei Ren
Huazhong Cai
Huazhong Cai
author_sort Yue Wang
collection DOAJ
description In recent years, the relationship between lipid metabolism and tumour immunotherapy has been thoroughly investigated. An increasing number of studies have shown that abnormal gene expression and ectopic levels of metabolites related to fatty acid synthesis or fatty acid oxidation affect tumour metastasis, recurrence, and drug resistance. Tumour immunotherapy that aims to promote an antitumour immune response has greatly improved the outcomes for tumour patients. However, lipid metabolism reprogramming in tumour cells or tumour microenvironment-infiltrating immune cells can influence the antitumour response of immune cells and induce tumor cell immune evasion. The recent increase in the prevalence of obesity-related cancers has drawn attention to the fact that obesity increases fatty acid oxidation in cancer cells and suppresses the activation of immune cells, thereby weakening antitumour immunity. This article reviews the changes in lipid metabolism in cells in the tumour microenvironment and describes the relationship between lipid metabolism reprogramming in multiple cell types and tumour immunotherapy.
first_indexed 2024-03-08T11:02:28Z
format Article
id doaj.art-b2a88f2082564ac09e4692c1fd0c3052
institution Directory Open Access Journal
issn 2296-634X
language English
last_indexed 2024-03-08T11:02:28Z
publishDate 2023-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cell and Developmental Biology
spelling doaj.art-b2a88f2082564ac09e4692c1fd0c30522024-01-26T15:45:47ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2023-05-011110.3389/fcell.2023.11879891187989Lipid metabolism and tumor immunotherapyYue Wang0Yue Wang1Yue Wang2Zongjin Guo3Adamu Danbala Isah4Shuangwei Chen5Yongfei Ren6Huazhong Cai7Huazhong Cai8School of Medicine, Jiangsu University, Zhenjiang, ChinaCancer Institute of Jiangsu University, Affiliated Hospital of Jiangsu University, Zhenjiang, ChinaDepartment of Emergency, Affiliated Hospital of Jiangsu University, Zhenjiang, ChinaDepartment of Interventional Radiology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, ChinaSchool of Medicine, Jiangsu University, Zhenjiang, ChinaSchool of Medicine, Jiangsu University, Zhenjiang, ChinaSchool of Medicine, Jiangsu University, Zhenjiang, ChinaCancer Institute of Jiangsu University, Affiliated Hospital of Jiangsu University, Zhenjiang, ChinaDepartment of Emergency, Affiliated Hospital of Jiangsu University, Zhenjiang, ChinaIn recent years, the relationship between lipid metabolism and tumour immunotherapy has been thoroughly investigated. An increasing number of studies have shown that abnormal gene expression and ectopic levels of metabolites related to fatty acid synthesis or fatty acid oxidation affect tumour metastasis, recurrence, and drug resistance. Tumour immunotherapy that aims to promote an antitumour immune response has greatly improved the outcomes for tumour patients. However, lipid metabolism reprogramming in tumour cells or tumour microenvironment-infiltrating immune cells can influence the antitumour response of immune cells and induce tumor cell immune evasion. The recent increase in the prevalence of obesity-related cancers has drawn attention to the fact that obesity increases fatty acid oxidation in cancer cells and suppresses the activation of immune cells, thereby weakening antitumour immunity. This article reviews the changes in lipid metabolism in cells in the tumour microenvironment and describes the relationship between lipid metabolism reprogramming in multiple cell types and tumour immunotherapy.https://www.frontiersin.org/articles/10.3389/fcell.2023.1187989/fulllipid metabolismtumor microenvironmentimmunotherapycombination therapyimmune cells
spellingShingle Yue Wang
Yue Wang
Yue Wang
Zongjin Guo
Adamu Danbala Isah
Shuangwei Chen
Yongfei Ren
Huazhong Cai
Huazhong Cai
Lipid metabolism and tumor immunotherapy
Frontiers in Cell and Developmental Biology
lipid metabolism
tumor microenvironment
immunotherapy
combination therapy
immune cells
title Lipid metabolism and tumor immunotherapy
title_full Lipid metabolism and tumor immunotherapy
title_fullStr Lipid metabolism and tumor immunotherapy
title_full_unstemmed Lipid metabolism and tumor immunotherapy
title_short Lipid metabolism and tumor immunotherapy
title_sort lipid metabolism and tumor immunotherapy
topic lipid metabolism
tumor microenvironment
immunotherapy
combination therapy
immune cells
url https://www.frontiersin.org/articles/10.3389/fcell.2023.1187989/full
work_keys_str_mv AT yuewang lipidmetabolismandtumorimmunotherapy
AT yuewang lipidmetabolismandtumorimmunotherapy
AT yuewang lipidmetabolismandtumorimmunotherapy
AT zongjinguo lipidmetabolismandtumorimmunotherapy
AT adamudanbalaisah lipidmetabolismandtumorimmunotherapy
AT shuangweichen lipidmetabolismandtumorimmunotherapy
AT yongfeiren lipidmetabolismandtumorimmunotherapy
AT huazhongcai lipidmetabolismandtumorimmunotherapy
AT huazhongcai lipidmetabolismandtumorimmunotherapy